Recent Analyst Forecasts and Stock Ratings
Biomarin Pharmaceutical Inc. FAQ's
Biomarin Pharmaceutical Inc. has been rated by research analysts at BMO Capital, H.C. Wainwright, Piper Sandler, Barclays, Canaccord Genuity, Raymond James in the past 90 days.